Manchester, United Kingdom

Matthew Lloyd Parry

This inventor holds 1 USPTO granted patent and 4 published patent applications and 2 EPO patents. Top assignee: Fujifilm Imaging Colorants, Inc.. Active years: 2010.

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Matthew Lloyd Parry: Innovator in Curable Ink Technology

Introduction

Matthew Lloyd Parry is a notable inventor based in Manchester, GB. He has made significant contributions to the field of ink technology, particularly with his innovative approach to curable inks. His work focuses on developing inks that are not only effective but also safe for food contact applications.

Latest Patents

Matthew holds a patent for a "Substantially solvent-free and photoinitiator-free curable ink." This non-aqueous ink has a viscosity of less than 30 m Pa·s at 60°C. The formulation is designed to be particle beam curable, making it particularly useful as inkjet printing inks. The inks demonstrate excellent fat resistance and low levels of leaching to foodstuffs, making them suitable for food contact applications.

Career Highlights

Matthew is currently employed at Fujifilm Imaging Colorants, Inc., where he continues to innovate in the field of ink technology. His work has garnered attention for its potential applications in various industries, particularly in food packaging and printing.

Collaborations

Matthew has collaborated with notable colleagues, including Andrew Stuart Overend and Janette Cordwell. These partnerships have contributed to the advancement of his research and the successful development of new ink technologies.

Conclusion

Matthew Lloyd Parry is a pioneering inventor whose work in curable ink technology is making a significant impact in the industry. His innovative solutions are paving the way for safer and more effective printing applications.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…